Resveratrol, a Natural Antioxidant, Has a Protective Effect on Liver Injury Induced by Inorganic Arsenic Exposure

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zhang, Zhigang ^a   Gao, Li ^a   Cheng, Yanyan ^a   Jiang, Jing ^a   Chen, Yan ^a   Jiang, Huijie ^a   Yu, Hongxiang ^a   Shan, Anshan ^a   Cheng, Baojing ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ARSENIC TRIOXIDE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; CHOLESTEROL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE; ANTIOXIDANT; ARSENIC; ORGANOARSENIC DERIVATIVE; OXIDE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CELL; LIVER FUNCTION; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; ADVERSE EFFECTS; ANIMAL; CAT; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; LIVER; LIVER DISEASES; METABOLISM; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; ARSENIC; ARSENICALS; CATS; ENVIRONMENTAL EXPOSURE; GLUTATHIONE; LIVER; LIVER DISEASES; MALONDIALDEHYDE; OXIDATIVE STRESS; OXIDES; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84928965113     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/617202     Document Type: Article

References (41)

1. S. J. Chen, G. B. Zhou, X. W. Zhang, J. H. Mao, H. DeThe, and Z. Chen, "From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia, " Blood, vol. 117, no. 24, pp. 6425-6437, 2011.
2. A. Jain, A. Yadav, A. I. Bozhkov, V. I. Padalko, and S. J. S. Flora, "Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats, " Ecotoxicology and Environmental Safety, vol. 74, no. 4, pp. 607-614, 2011.
3. B. Chen, L. L. Arnold, S. M. Cohen, D. J. Thomas, and X. C. Le, "Mouse arsenic (+3 oxidation state) methyltransferase genotype affects metabolism and tissue dosimetry of arsenicals after arsenite administration in drinking water, " Toxicological Sciences, vol. 124, no. 2, pp. 320-326, 2011.
4. L. Mathew, A. Vale, and J. E. Adcock, "Arsenical peripheral neuropathy, " Practical Neurology, vol. 10, no. 1, pp. 34-38, 2010.
5. A. Anwar-Mohamed, G. Abdelhamid, I. E. A. Amara, and A. O. S. El-Kadi, "Differential modulation of aryl hydrocarbon receptor regulated enzymes by arsenite in the kidney, lung, and heart of C57BL/6 mice, " Archives of Toxicology, vol. 86, no. 6, pp. 897-910, 2012.
6. M. Messarah, F. Klibet, A. Boumendjel, et al., "Hepatoprotective role and antioxidant capacity of selenium on arsenic-induced liver injury in rats, " Experimental and Toxicologic Pathology, vol. 64, no. 3, pp. 167-174, 2012.
7. L. Benramdane, M. Accominotti, L. Fanton, D. Malicier, and J. Vallon, "Arsenic speciation in human organs following fatal arsenic trioxide poisoning-a case report, " Clinical Chemistry, vol. 45, no. 2, pp. 301-306, 1999.
8. M. K. Paul, R. Kumar, and A. K. Mukhopadhyay, "Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells, " Toxicology and Applied Pharmacology, vol. 226, no. 2, pp. 140-152, 2008.
9. S. Ghosh, S. R. Dungdung, S. T. Chowdhury, et al., "Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress, " Free Radical Biology and Medicine, vol. 51, no. 10, pp. 1893-1902, 2011.
10. C. Loguercio and A. Federico, "Oxidative stress in viral and alcoholic hepatitis, " Free Radical Biology and Medicine, vol. 34, no. 1, pp. 1-10, 2003.
11. X. Zhu, Q. Liu, M. Wang, et al., "Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts., " PloS ONE, vol. 6, no. 11, Article ID e27081, 2011.
12. O. F. Dyson, L. R. Walker, A. Whitehouse, P. P. Cook, and S. M. Akula, "Resveratrol inhibits KSHV reactivation by lowering the levels of cellular Egr-1, " PLoS ONE, vol. 7, no. 3, Article ID e33364, 2012.
13. I. Gulcin, "Antioxidant activity of food constituents: an overview, " Archives of Toxicology, vol. 86, pp. 345-391, 2012.
14. W. Q. Zhang, C. Y. Yao, M. Ge, et al., "Attenuation of arsenic retention by resveratrol in lung of arsenic trioxide-exposed rats, " Environmental Toxicology and Pharmacology, vol. 36, no. 1, pp. 35-39, 2013.
15. M. Yu, J. Xue, Y. Li, et al., "Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress, " Archives of Toxicology, vol. 87, no. 6, pp. 1025-1035, 2013.
16. J. A. Baur, K. J. Pearson, N. L. Price, et al., "Resveratrol improves health and survival of mice on a high-calorie diet, " Nature, vol. 444, no. 7117, pp. 337-342, 2006.
17. H. Colom, I. Alfaras, M. Maijo, M. E. Juan, and J. M. Planas, "Population pharmacokinetic modeling of trans-resveratrol and its glucuronide and sulfate conjugates after oral and intravenous administration in rats, " Pharmaceutical Research, vol. 28, no. 7, pp. 1606-1621, 2011.
18. A. Kasdallah-Grissa, B. Mornagui, E. Aouani, et al., "Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver, " Life Sciences, vol. 80, no. 11, pp. 1033-1039, 2007.
19. S. Garvin, K. Ollinger, and C. Dabrosin, "Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo, " Cancer Letters, vol. 231, no. 1, pp. 113-122, 2006.
20. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi, "Combined effects of resveratrol and paclitaxel on lung cancer cells, " Anticancer Research, vol. 23, no. 5 A, pp. 4039-4046, 2003.
21. Y. A. Rezk, S. S. Balulad, R. S. Keller, and J. A. Bennett, "Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart, " The American Journal of Obstetrics and Gynecology, vol. 194, no. 5, pp. e23-e26, 2006.
22. B. Hughes, B. R. Madan, and J. R. Parratt, "PolymyxinBsulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin, " The British Journal of Pharmacology, vol. 74, no. 3, pp. 701-707, 1981.
23. J. M. Giraudel, A. Diquelou, V. Laroute, P. Lees, and P. Toutain, "Pharmacokineti/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat, " British Journal of Pharmacology, vol. 146, no. 5, pp. 642-653, 2005.
24. M. Mokni, S. Elkahoui, F. Limam, M. Amri, and E. Aouani, "Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat, " Neurochemical Research, vol. 32, no. 6, pp. 981-987, 2007.
25. D. J. Socci, K. B. Bjugstad, H. C. Jones, J. V. Pattisapu, and G. W. Arendash, "Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model, " ExperimentalNeurology, vol. 155, no. 1, pp. 109-117, 1999.
26. X. Cui, Y. Kobayashi, T. Hayakawa, and S. Hirano, "Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats, " Toxicological Sciences, vol. 82, no. 2, pp. 478-487, 2004.
27. S. J. Flora, "Arsenic-induced oxidative stress and its reversibility, " Free Radical Biology & Medicine, vol. 51, no. 2, pp. 257-281, 2011.
28. L. Wang, M. Kou, C. Weng, L. Hu, Y. Wang, and M. Wu, "Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-kB, and MAPK pathways, " Archives of Toxicology, vol. 86, no. 6, pp. 879-896, 2012.
29. H. Naranmandura, S. Xu, S. Koike, et al., "The endoplasmic reticulum is a target organelle for trivalent dimethylarsinic acid (DMAIII)-induced cytotoxicity, " Toxicology and Applied Pharmacology, vol. 260, no. 3, pp. 241-249, 2012.
30. H. Naranmandura, S. Xu, T. Sawata, et al., "Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA III)-induced cytotoxicity, " Chemical Research in Toxicology, vol. 24, no. 7, pp. 1094-1103, 2011.
31. S. X. Liu, M. Athar, I. Lippai, C. Waldren, and T. K. Hei, "Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 1643-1648, 2001.
32. J. Zheng, L. Chen, H. Zhang, X. Hu, W. Kong, and D. Hu, "Resveratrol improves insulin resistance of catch-up growth by increasing mitochondrial complexes and antioxidant function in skeletalmuscle, " Metabolism, vol. 61, no. 7, pp. 954-965, 2012.
33. R. Anderson and T. Prolla, " PGC-1α in aging and anti-aging interventions, " Biochimicaet Biophysica Acta, vol. 1790, no. 10, pp. 1059-1066, 2009.
34. B. Olas, P. Nowak, J. Kolodziejczyk, M. Ponczek, and B. Wachowicz, "Protective effects of resveratrol against oxidative/nitrative modifications of plasma proteins and lipids exposed to peroxynitrite, " Journal of Nutritional Biochemistry, vol. 17, no. 2, pp. 96-102, 2006.
35. E. L. Robb and J. A. Stuart, "Resveratrol interacts with estrogen receptor-β to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondrial superoxide dismutase, " Free Radical Biology and Medicine, vol. 50, no. 7, pp. 821-831, 2011.
36. S. J. Park, F. Ahmad, A. Philp, et al., "Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases, " Cell, vol. 148, no. 3, pp. 421-433, 2012.
37. C. M. Diaz-Montero, Y. Wang, L. Shao, et al., "The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamideinduced hematopoietic and immune suppression by reducing oxidative stress, " Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1560-1568, 2012.
38. E. M. Leslie, "Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs), " Journal of Inorganic Biochemistry, vol. 108, pp. 141-149, 2012.
39. M. W. Carew, H. Naranmandura, C. B. Shukalek, X. C. Le, and E. M. Leslie, "Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1), " Drug Metabolism and Disposition, vol. 39, no. 12, pp. 2298-2304, 2011.
40. P. Ong, S. Chan, and P. C. Ho, "Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and-dependent cytotoxic potentiation, " International Journal of Oncology, vol. 38, no. 6, pp. 1731-1739, 2011.
41. S. Hassan-Khabbar, C. H. Cottart, D. Wendum, et al., "Postischemic treatment by trans-resveratrol in rat liver ischemiareperfusion: a possible strategy in liver surgery, " Liver Transplantation, vol. 14, no. 4, pp. 451-459, 2008.